Current Understanding of PCSK۹ and Its Relevance to Cancer Prognosis and Immune Therapy: A Review

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 142

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJP-19-1_001

تاریخ نمایه سازی: 17 بهمن 1402

چکیده مقاله:

The effectiveness of immunotherapy for most cancer patients remains low, with approximately ۱۰–۳۰% of those treated surviving. Thus, much effort is being put into finding new ways to improve immune checkpoint therapy. Our review concludes that the inhibition of proprotein convertase subtilisin/Kexin type ۹ (PCSK۹), which plays a critical role in regulating cholesterol metabolism, can cause T cells to move toward tumors, with increased sensitivity to immune checkpoint therapies.We searched PubMed, NCBI, Scopus, and Google Scholar for the published articles without limitations on publication dates. We used the following terms: “PCSK۹”, “Cancer”, “Immune Checkpoint”, and “Cancer Prognosis” in the title and/or abstract. Our search initially revealed ۶۰۰ records on the subject and stored them in the used databases under EndNote X۸ management software. We selected about ۱۶۱ articles that were carefully read and among them, ۷۶ were included in our research.We concluded that PCSK۹ reduces the number of LDL receptors (LDL-R) on the cell surface, which is linked to its ability to regulate cholesterol levels in the body. Also, we discuss how suppressing PCSK۹ leads to the MHC-۱ accumulation on the surface of cancer cells, which results in T lymphocyte invasion. Finally, we believe that inhibiting PCSK۹ may be an effective strategy for improving cancer immunotherapy.

کلیدواژه ها:

نویسندگان

Morteza Hassandokht Mashhadi

Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran

Fahimeh Taheri

B.Sc. of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran

Sadaf Irani

Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran

Arshiya Mesbah Mousavi

Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran

Ali Mehri

Endoscopic and Minimally Invasive Surgery Research Center, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran

Hossein Javid

Department of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Bhat M, Skill N, Marcus V, Deschenes M, Tan X, ...
  • Karimi-Shahri M, Khorramdel M, Zarei S, Attarian F, Hashemian P, ...
  • Webb ES, Liu P, Baleeiro R, Lemoine NR, Yuan M, ...
  • نمایش کامل مراجع